Skeletal Dynamics, Inc. appears in FDA records as the applicant for an orthopedic device clearance, while its own published material describes an upper extremity focus. The FDA file documents the Trochlear Salvage Plating System. The company states that it was founded in 2007 and that the upper extremity surgeon’s perspective guides its decisions. Those company statements describe its published positioning rather than the scope of a specific FDA decision. [1][4][6]

The documented FDA clearance

K261135 covers the Trochlear Salvage Plating System, submitted by Skeletal Dynamics, Inc. as a Traditional 510(k). FDA recorded receipt on 2026-04-07 and a decision of Substantially Equivalent (SESE) on 2026-10-26. The device sits in product code HRS, regulation 21 CFR 888.3030, device class 2, with the orthopedic advisory committee and the classification name Plate, Fixation, Bone. The submission was not third-party reviewed and carried a Summary statement. [1][7][8]

An FDA letter in the file addresses the applicant's Director of Regulatory Affairs at 7300 N. Kendall Dr. Suite 800 and cites the same regulation and product code, listing HRS and OZI together. The letter is dated September 23, 2026 and recorded as received September 24, 2026. That correspondence address is a filing detail, not evidence of a corporate headquarters. [5]

Company identity and stated focus

Skeletal Dynamics publishes that it was founded in 2007 and that its mission is to become the premier upper extremity company, organized around four stated pillars. Its site describes an exclusively upper extremity orientation and frames its work around the clinical challenges of upper extremity surgery. These are the company's own characterizations of itself, published on its website. [4][6]

The same pages describe a distribution model in which the company selects distributors on integrity, clinical knowledge and industry experience, with the stated aim of supporting the pre-operative, intra-operative and post-operative cycle. No independent verification of that model appears in the public documents. [6]

Product scope as published

Company pages name a Proximal Humerus Fixation System, described as engineered for stability, subchondral support and resistance to varus collapse using a central peg surrounded by anatomically divergent screws, and a Hand Nailing Set. A soft tissue area links to a distal biceps repair product page. These are product descriptions from the company's own site; the sources do not establish clearance status, availability or performance for them. [3]

Only the Trochlear Salvage Plating System is documented in the linked FDA records. The company's published product names and the cleared device should be read as separate pieces of information rather than a single verified catalog. [1][3]

What the record does and does not show

As of the snapshot date, the supplied collection holds one linked record, a 510(k) with a SESE decision, and the smaller record sample likewise contains that one entry. These counts describe the supplied filings only; they are not measures of total portfolio, sales or safety performance. No recall records appear in the supplied sample. [1]

Ownership, parent entities, customers and commercial availability are not established by the public documents. The company's site lists a Miami, Florida address and contact channels, and FDA records list a Miami, FL applicant location; neither is treated here as a verified headquarters designation beyond what each publisher states. [1][3][4]